Sign in

CIK 0001437402

  • Large accelerated filer

ARDELYX, INC.

Sign in to watch
Ticker
ARDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 510-745-7047
Business address
34175 ARDENWOOD BLVD., FREMONT, CA, 94555
Former names
NTERYX INC
  1. 4 Open-market sale Chief Commercial Officer sold 10,439 shares at an average $5.85 ($61,034)
  2. 4 Grant or award See Remarks acquired 46,200 shares (grant or award)
  3. 4 Grant or award See Remarks acquired 103,080 shares (grant or award)
  4. 4 Grant or award Chief Financial Officer acquired 85,670 shares (grant or award)
  5. 4 Grant or award Chief Commercial Officer acquired 137,945 shares (grant or award)
  6. 4 Grant or award President & CEO acquired 446,220 shares (grant or award)
  7. 4 Grant or award Chief Human Resources Officer acquired 99,455 shares (grant or award)
  8. 4 Grant or award Chief Patient Officer acquired 82,695 shares (grant or award)
  9. 4 Grant or award See Remarks acquired 124,330 shares (grant or award)
  10. 4 Planned sale Chief Patient Officer sold 50,000 shares at $6.98 ($348,900)
  11. 4 Open-market sale See Remarks sold 5,995 shares at $5.54 ($33,194)
  12. 4 Open-market sale President & CEO sold 46,887 shares at $5.54 ($259,609)
  13. 4 Open-market sale See Remarks sold 5,560 shares at $5.54 ($30,785)
  14. 4 Open-market sale Chief Patient Officer sold 6,426 shares at $5.54 ($35,580)
  15. 4 Open-market sale Chief Commercial Officer sold 5,814 shares at $5.54 ($32,192)
  16. 4 Open-market sale See Remarks sold 11,086 shares at $5.54 ($61,382)
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 3 of 35 · 690 filings